title: Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
authors.affiliation: NYU Medical Center, New York, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Ferris
authors.forename: U
authors.initials: U
authors.lastname: Lucca
authors.forename: R
authors.initials: R
authors.lastname: Mohs
authors.forename: B
authors.initials: B
authors.lastname: Dubois
authors.forename: K
authors.initials: K
authors.lastname: Wesnes
authors.forename: H
authors.initials: H
authors.lastname: Erzigkeit
authors.forename: D
authors.initials: D
authors.lastname: Geldmacher
authors.forename: N
authors.initials: N
authors.lastname: Bodick
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy*; D015577:Geriatric Assessment / Q000706:statistics & numerical data*; D006801:Humans; D007391:International Cooperation; D009483:Neuropsychological Tests / Q000706:statistics & numerical data*; D018697:Nootropic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011594:Psychometrics; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D018697:Nootropic Agents